Health
AI in Biotech and Regulatory Diversity
Biotech companies are embracing AI, according to STAT News. Meanwhile, GOP lawmakers push the FDA for more diverse clinical trials.
Coverage timeline — 3 articles
STAT News
Call AI in biotech hype at your peril. There are real reasons that pharmaceutical companies are embracing this technology right now.
2026-07-06 08:30 UTC
STAT News
Supporters say clinical trial diversity is about making sure drugs and devices work, not about DEI.
2026-07-06 08:30 UTC
STAT News
“The medical industry has spent enormous effort making more advanced tests but expended little effort learning how to use tests correctly,” writes Daniel Morgan.
2026-07-06 08:30 UTC